You are here

Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
University Hospital of Alexandroupolis Dimokritio
Alexandroupolis, Thrace, 68100 Greece
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Alzheimer Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Diagnosis of Alzheimer's Disease

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- There are no exclusion criteria

NCT01089582
Pfizer
Completed
Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Alzheimer Disease
NCT00996918
All Genders
51+
Years
Multiple Sites
Alzheimer Disease, Healthy Subjects
NCT00795730
All Genders
18+
Years
Glendale, California

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now